Veronica Smith

Validation and application of Caco-2 assays for the<b><i>in vitro</i></b>evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions

Robert Elsby, Dominic Surry, Veronica Smith et al. · Xenobiotica · 2008 · 141 citations

Pharmaceutical Science, Cellular Pharmacology, Development Candidate Drugs +24

Prediction of the in vivo OATP1B1-mediated drug–drug interaction potential of an investigational drug against a range of statins

Pradeep Sharma, Caroline Butters, Veronica Smith et al. · European Journal of Pharmaceutical Sciences · 2012 · 52 citations

Pharmacological Study, Biochemistry, Medicine +6

Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions

Robert Elsby, Veronica Smith, Lisa Fox et al. · Xenobiotica · 2011 · 36 citations

In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug–drug interaction with methotrexate

Robert Elsby, Lisa Fox, David M. Stresser et al. · European Journal of Pharmaceutical Sciences · 2011 · 31 citations

Drug Safety, Drug Interactions, Vitro Risk Assessment +13

The Utility of In Vitro Data in Making Accurate Predictions of Human P-Glycoprotein-Mediated Drug-Drug Interactions: A Case Study for AZD5672

Robert Elsby, Michael Gillen, Caroline Butters et al. · Drug Metabolism and Disposition · 2010 · 23 citations